Latest Maggot therapy Stories
ZUG, Switzerland and CANTON, Mass., May 26 /PRNewswire/ -- Organogenesis Switzerland GmbH will sponsor a symposium on ApligrafÂ®, a bilayered living cellular construct for the treatment of chronic wounds and soft tissue repair, at the upcoming European Wound Management Association (EWMA) conference.
SAN DIEGO, May 25 /PRNewswire/ -- CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGONÂ® in patients with chronic venous leg ulcers.
Bacteria that infect chronic wounds can be deadly to maggot 'biosurgeons' used to treat the lesions, show researchers writing in the journal Microbiology.
IRVINE, Calif., Oct. 6 /PRNewswire/ -- Monarch Labs LLC, the exclusive supplier of Medical Maggots(TM) in the United States, announced today that it has partnered with MNX to provide expedited shipping of the Medical Maggots(TM) product (disinfected Phaenicia sericata larvae) for maggot therapy.
IRVINE, Calif., Sept. 22 /PRNewswire/ -- Monarch Labs LLC, the exclusive supplier of Medical Maggots(TM) in the United States, announced today that its Laboratory Director and co-founder, Dr.
NEW YORK, Sept.
SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds.
A UK study suggests that flesh-eating maggots may not have the miracle healing properties that have been claimed.
Doctors predict that spray-on skin cells will be used as a common form of sore treatment in the Swedish healthcare system within a few years.
Orthovita, Inc. (NASDAQ:VITA), a spine and orthopedic biosurgery company, reported that it has received CE Mark approval for its VITAGELÂ® Surgical Hemostat product and CELLPAKERÂ® plasma collection system. The approval allows Orthovita to market VITAGEL as a surgical hemostat in Europe.